272 related articles for article (PubMed ID: 10746844)
1. Factors associated with climacteric symptoms and the use of hormone replacement therapy.
Stadberg E; Mattsson LA; Milsom I
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):286-92. PubMed ID: 10746844
[TBL] [Abstract][Full Text] [Related]
2. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
Oddens BJ; Boulet MJ
Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
[TBL] [Abstract][Full Text] [Related]
4. Oral symptoms at menopause--the role of hormone replacement therapy.
Tarkkila L; Linna M; Tiitinen A; Lindqvist C; Meurman JH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):276-80. PubMed ID: 11552144
[TBL] [Abstract][Full Text] [Related]
5. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
[TBL] [Abstract][Full Text] [Related]
6. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
Thunell L; Stadberg E; Milsom I; Mattsson LA
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):395-401. PubMed ID: 15762973
[TBL] [Abstract][Full Text] [Related]
7. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
[TBL] [Abstract][Full Text] [Related]
8. [Estrogen and natural products in the treatment of postmenopausal complaints. Oral contraceptives prepare the way for hormonal substitution].
Hammar M; Frisk J; Brynhildsen J; Dabrosin L; Lindgren R; Nedstrand E; Wyon Y
Lakartidningen; 1997 Mar; 94(12):1084-8. PubMed ID: 9121242
[TBL] [Abstract][Full Text] [Related]
9. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
Lucas R; Barros H
Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
[TBL] [Abstract][Full Text] [Related]
10. Treatment of climacteric symptoms in Finland prior to the controversial reports on hormone therapy.
Jalava-Broman J; Mäkinen J; Ojanlatva A; Jokinen K; Sillanmäki L; Rautava P
Acta Obstet Gynecol Scand; 2008; 87(6):682-6. PubMed ID: 18568469
[TBL] [Abstract][Full Text] [Related]
11. Use of hormone replacement therapy in Italian women aged 50-70 years.
Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
14. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
[TBL] [Abstract][Full Text] [Related]
15. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
Bakken K; Eggen AE; Lund E
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with treatment options among menopausal women in Taiwan.
Chiou YW; Tai CJ; Chien LY
Maturitas; 2006 Jun; 54(3):205-12. PubMed ID: 16303267
[TBL] [Abstract][Full Text] [Related]
17. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
18. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists.
Castelo-Branco C; Ferrer J; Palacios S; Cornago S
Maturitas; 2006 Nov; 55(4):308-16. PubMed ID: 16730140
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study.
Shargil AA
Int J Fertil; 1985; 30(1):15, 18-28. PubMed ID: 2862116
[TBL] [Abstract][Full Text] [Related]
20. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy.
Bhavnani V; Clarke A
BJOG; 2003 Feb; 110(2):168-74. PubMed ID: 12618161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
